SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001193125-10-274564
Filing Date
2010-12-06
Accepted
2010-12-06 16:02:00
Documents
5
Period of Report
2009-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K AMENDMENT NO. 1 d10ka.htm 10-K/A 90400
2 RULE 13A-14(A) CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER dex311.htm EX-31.1 10116
3 RULE 13A-14(A) CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER dex312.htm EX-31.2 10326
4 SECTION 1350 CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER dex321.htm EX-32.1 4174
5 SECTION 1350 CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER dex322.htm EX-32.2 4389
  Complete submission text file 0001193125-10-274564.txt   120851
Mailing Address 950 TOWER LANE SUITE 900 FOSTER CITY CA 94404-2125
Business Address 950 TOWER LANE SUITE 900 FOSTER CITY CA 94404-2125 650-358-3456
SCICLONE PHARMACEUTICALS INC (Filer) CIK: 0000880771 (see all company filings)

IRS No.: 943116852 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 000-19825 | Film No.: 101234306
SIC: 2834 Pharmaceutical Preparations